-
Study finds tocilizumab improves survival in critically ill patients with COVID-19
worldpharmanews
October 23, 2020
Researchers from 68 sites across the country, led by David E. Leaf, MD, MMSc and Shruti Gupta, MD, MPH from the Division of Renal Medicine at Brigham and Women's Hospital, have investigated the effects of the anti-inflammatory drug tocilizumab on ...
-
Hackensack Meridian Health Observational Study Identifies Drug that Improves Survival in Sickest COVID-19 Patients
prnewswire
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in ...
-
Observational study identifies drug that improves survival in sickest COVID-19 patients
worldpharmanews
August 20, 2020
Researchers at Hackensack Meridian Health, New Jersey's largest and most comprehensive health network, have utilized its statewide observational database of more than 5,000 hospitalized COVID-19 patients to show that a drug normally used in rheumatoid ...
-
Maha FDA seizes 15 vials of tocilizumab black marketed at Rs one lakh each
expresspharma
August 05, 2020
The Maharashtra Food and Drug Administration (FDA) has seized 15 vials of tocilizumab from a non-authorised license holder in Bandra, Mumbai. The team has arrested and filed an FIR against him.
-
Maha FDA files FIR against five people, guilty in blackmarketing of remedisivir and tocilizumab
expresspharma
July 24, 2020
The team seized medicines worth Rs 3,13,482 for COVID-19 and other therapeutic categories.
-
We are monitoring sale, supply of medicines for COVID-19 treatment: Haryana FDA
expresspharma
July 20, 2020
Haryana Medical Services Corporation (HMSC) has procured 400 vials of remdesivir and tocilizumab from Cipla to ensure availability of key drugs.
-
Indiscriminate use led to bogus tocilizumab injections: FDCA
expresspharma
July 20, 2020
A racket selling spurious tocilizumab injections which are used in the treatment of COVID-19 was recently busted following raids in Surat and Ahmedabad.
-
Tocilizumab lowers risk of death for critical COVID-19 patients on ventilators, finds study
europeanpharmaceuticalreview
July 16, 2020
Patients who received tocilizumab in the retrospective, single-centre study were 45 percent less like to die and more likely to come off ventilation within 28 days.
-
Drug linked to 45% lower risk of dying among COVID-19 patients on ventilators
worldpharmanews
July 15, 2020
Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment ...
-
Remdesivir, tocilizumab and CPT included in revised protocols for COVID-19 clinical management
expresspharma
June 15, 2020
Hydroxychloroquine can be prescribed in the early stages of COVID-19 infection but not for patients with severe disease, use of azithromycin has been discontinued.